Tamara L Wexler MD, PhD's portrait

Tamara L Wexler MD, PhD

NYU Langone Medical Center
New York, NY
Dr. Wexler is a member of the EndocrineWeb Editorial Board.

About Tamara L Wexler MD, PhD

Tamara L. Wexler, MD, PhD, is an endocrinologist, specializing in neuroendocrinology and reproductive endocrinology. Dr. Wexler has served as an attending physician in internal medicine at the Massachusetts General Hospital, in Boston, MA, and as director of the NYU Langone Medical Center Pituitary Center in New York, NY, where she currently serves as the lead principal investigator of TBI/Pituitary registry and lead site investigator for a multisite neuroendocrine study.

Dr. Wexler received her medical degree and PhD in neuroscience from the University of Pennsylvania, conducting dissertation research into the pathophysiology of Kallmann’s Syndrome at the University of Pennsylvania and the National Institutes of Health. She completed her residency in Internal Medicine and her fellowship in Endocrinology, Diabetes, and Metabolism at Massachusetts General Hospital, focusing on neuroendocrinology, where she designed and ran national clinical trials.

While remaining on staff at Massachusetts General Hospital, Dr. Wexler worked for four years at McKinsey & Company, where she served as the US Lead for Diabetes and Obesity, Global Lead for other Endocrinology, and as an Expert to McKinsey in Reproductive Health and its R&D, regulatory, clinical, and market dynamics. She continues to independently consult on research and development issues, focusing on incorporating government, payer, provider, and patient viewpoints in addressing healthcare issues.  She reviewed grants for the Bill and Melinda Gates Foundation in the area of reproductive health, and is on the Leadership Council of the University of Pennsylvania Institute for Diabetes, Obesity, and Metabolism.

She is a member of the Endocrine Society, for which she served on the Advocacy and Public Outreach core committee from 2008-2011 and now serves on the Scientific and Education Programs Core Committee, and is an associate editor for the new Endocrine Society-Medscape education venture. She has served as an invited speaker and moderator at academic medical centers and national conferences.  Her publications appear in journals such as Journal of Clinical Endocrinology & Metabolism and Clinical Endocrinology.



Lin E, Wexler TL, Nachtigall L, Tritos N, Swearingen B, Hemphill L, et al. Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly. Clin Endocrinol. 2012;77(3):430-438.

Miller KK, Wexler T, Fazeli P, Gunnell L, Graham GJ, Beauregard C, et al. Growth hormone deficiency after treatment of acromegaly: a randomized, placebo-controlled study of growth hormone replacement.JCEM. 2010;95(2):567-577.

Wexler TL, Durst R, McCarty D, Picard MH, Gunnell L, Omer Z, et al. Growth hormone status predicts left ventricular mass in patients after cure of acromegaly. Growth Hormone & IGF Research. 2010;20(5):333-337.

Lawson EA, Donoho D, Miller KK, Misra M, Meenaghan E, Lydecker J, Wexler T, et al. Hypercortisolemia is associated with severity of bone loss and depression in hypothalamic amenorrhea and anorexia nervosa. JCEM. 2009;94(12):4710-4716.

Wexler T, Tunnell L, Omer Z, Kihlthau K, Beauregard C, Graham G, et al. Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. JCEM. 2009;94(7):2471-2477.

Moore AF, Wexler TL, Yung TL, Kish J, Larvie M, Lauter K, et al. An unusual case of primary hyperparathyroidism with profoundly elevated parathyroid hormone levels. Endocrine Practice. 2008;14(7):892-897.

Miller KK, Lawson EA, Mathur V, Wexler TL, Meenaghan E, Misra M, et al. Androgens in women with anorexia nervosa and normal-weight women with hypothalamic amenorrhea. JCEM. 2007;92(4):1334-1339.

Miller KK, Wexler TL, Zha AM, Lawson EA, Meenaghan E, Misra M, et al. Androgen deficiency: association with increased anxiety and depression symptom severity in anorexia nervosa. J Clin Psychiatry.  2007;68(6):959-965.

Renzi MJ, Wexler TL, Raper JA. Olfactory sensory axons expressing a dominant-negative semaphorin receptor enter the CNS early and overshoot their target. Neuron. 2000;28(2):437-447.

Deschenes SM, Walcott JL, Wexler TL, Scherer SS, Fischbeck KH. Altered trafficking of mutant connexin32. J Neurosci. 1997:17(23):9077-9084.

Financial Disclosures for Tamara L Wexler MD, PhD

EndocrineWeb, a Remedy Health Media, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.

To help achieve this goal, EndocrineWeb requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.

The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.

Author's Statement

I, the undersigned, declare that neither I nor members of my immediate family have a financial interests or affiliation with commercial companies whose products and / or services may be mentioned in the materials I have authored, edited or reviewed for presentation on Remedy Health Media, LLC’s websites.
There are no disclosures for this author